Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Summary Literature (4)
Literature for DOID 2033: communication disorder


Xenbase Articles :
( Denotes literature images)
Transcriptional regulator PRDM12 is essential for human pain perception., Chen YC,Chen YC,Auer-Grumbach M,Matsukawa S,Zitzelsberger M,Themistocleous AC,Strom TM,Samara C,Moore AW,Cho LT,Young GT,Weiss C,Schabhüttl M,Stucka R,Schmid AB,Parman Y,Graul-Neumann L,Heinritz W,Passarge E,Watson RM,Hertz JM,Moog U,Baumgartner M,Valente EM,Pereira D,Restrepo CM,Katona I,Dusl M,Stendel C,Wieland T,Stafford F,Reimann F,von Au K,Finke C,Willems PJ,Nahorski MS,Shaikh SS,Carvalho OP,Nicholas AK,Karbani G,McAleer MA,Cilio MR,McHugh JC,Murphy SM,Irvine AD,Jensen UB,Windhager R,Weis J,Bergmann C,Rautenstrauss B,Baets J,De Jonghe P,Reilly MM,Kropatsch R,Kurth I,Chrast R,Michiue T,Bennett DL,Woods CG,Senderek J, Nat Genet. July 1, 2015; 47(7):1546-1718.
Prdm12 Directs Nociceptive Sensory Neuron Development by Regulating the Expression of the NGF Receptor TrkA., Desiderio S,Vermeiren S,Van Campenhout C,Kricha S,Malki E,Richts S,Fletcher EV,Vanwelden T,Schmidt BZ,Henningfeld KA,Pieler T,Woods CG,Nagy V,Verfaillie C,Bellefroid EJ, Cell Rep. March 26, 2019; 26(13):2211-1247.
From cohorts to molecules: Adverse impacts of endocrine disrupting mixtures., Caporale N,Leemans M,Birgersson L,Germain PL,Cheroni C,Borbély G,Engdahl E,Lindh C,Bressan RB,Cavallo F,Chorev NE,D'Agostino GA,Pollard SM,Rigoli MT,Tenderini E,Tobon AL,Trattaro S,Troglio F,Zanella M,Bergman Å,Damdimopoulou P,Jönsson M,Kiess W,Kitraki E,Kiviranta H,Nånberg E,Öberg M,Rantakokko P,Rudén C,Söder O,Bornehag CG,Demeneix B,Fini JB,Gennings C,Rüegg J,Sturve J,Testa G, Science. February 18, 2022; 375(6582):1095-9203.
Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery., O'Connor EC,Kambara K,Bertrand D, Expert Opin Drug Discov. February 1, 2024; 19(2):1746-045X.